tirzepatide life md Weight Loss Injections • Fit 4 Weight Loss Medical Center Tirzepatide

Sources Nature Medicine: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial PubMed: Tirzepatide Once Weekly for the Treatment of Obesity Cleveland Clinic Journal of Medicine: Tirzepatide adds significant weight loss even after lifestyle changes MedicalNewsToday: How to Travel with Zepbound FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Important Current Status Update : On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide

You should expect to lose weight while taking tirzepatide

This informs the physician and insurer that weight loss could be an indication of some medical condition

Think of peptides as little messengers

Researchers conducted emulated target trials among 1,094,761 eligible patients with T2DM who had not been previously diagnosed with AD

For example, semaglutide 2.4mg (Wegovy) has demonstrated approximately 15% weight loss at 68 weeks in clinical trials, while liraglutide 3mg (Saxenda) typically achieves around 8% at 56 weeks